ÂÜÀòÂÒÂ×

The Leadership Team at QED Therapeutics is responsible for setting the strategic vision and guiding the company's efforts in developing precision medicine for FGFR-driven disorders. This team, consisting of key executives such as the CEO and SVPs, oversees research, regulatory compliance, and operational efficiencies, ensuring alignment with the company's goals in advancing innovative therapies like infigratinib. Their collaborative leadership drives the organization's growth and success in the competitive biotech landscape.